Literature DB >> 12475746

Arginase inhibition slows the progression of renal failure in rats with renal ablation.

Massimo Sabbatini1, Antonio Pisani, Francesco Uccello, Giorgio Fuiano, Raffaele Alfieri, Antonio Cesaro, Bruno Cianciaruso, Vittorio E Andreucci.   

Abstract

Exogenous arginine slows the progression of chronic renal failure (CRF) in remnant rats through a nitric oxide (NO)-dependent mechanism. We tested whether the inhibition of arginase could induce similar results through the increased availability of endogenous arginine. Three groups of remnant rats were studied for 8 wk: 1) untreated rats (REM); 2) remnant rats treated with 1% l-arginine (ARG); and 3) remnant rats administered a Mn(2+)-free diet to inhibit arginase (MNF). Normal rats (NOR) were used as controls. Liver arginase activity was depressed in MNF rats (-35% vs. REM, P < 0.01). No difference in metabolic data was detected among the groups throughout the study; blood pressure was significantly lower in MNF vs. ARG and REM rats after 6 wk (P < 0.001). The glomerular filtration rate (GFR) was greatly depressed in REM rats (-47% vs. NOR, P < 0.03) but was higher in ARG and MNF rats (+40 and +43% vs. REM, respectively, P < 0.05), with comparable changes in renal hemodynamics. Despite the better GFR, proteinuria was decreased in both ARG and MNF rats (-42%, P < 0.05, and -57%, P < 0.01, respectively, vs. REM rats). Arginine plasma levels, significantly reduced in REM rats (-41% vs. NOR, P < 0.01), were partially restored in MNF rats (+38% vs. REM), and urinary nitrite excretion, greatly depressed in REM rats (-76% vs. NOR, P < 0.01), was significantly increased in MNF rats (+209% vs. REM, P < 0.05). At the renal level, arginase activity was only slightly depressed in MNF rats (-18% vs. REM), but intrarenal concentrations of arginine were lower in this latter group (P < 0.05 vs. other groups). Beyond the hemodynamic modifications, MNF rats showed a lower glomerular sclerosis index (P < 0.05 vs. REM and ARG). Inhibition of arginase slows the progression of CRF in remnant rats similarly to arginine-treated rats; the better histological protection in MNF rats, however, suggests that additional factors are involved in these modifications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475746     DOI: 10.1152/ajprenal.00270.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury.

Authors:  Antonio Pisani; Massimo Sabbatini; Eleonora Riccio; Roberta Rossano; Michele Andreucci; Clemente Capasso; Viviana De Luca; Vincenzo Carginale; Mariano Bizzarri; Antonella Borrelli; Antonella Schiattarella; Michele Santangelo; Aldo Mancini
Journal:  Clin Exp Nephrol       Date:  2013-06-27       Impact factor: 2.801

Review 2.  Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

Review 3.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

Review 4.  The potential use of biomarkers in predicting contrast-induced acute kidney injury.

Authors:  Michele Andreucci; Teresa Faga; Eleonora Riccio; Massimo Sabbatini; Antonio Pisani; Ashour Michael
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-09

5.  Selective inhibition of arginase-2 in endothelial cells but not proximal tubules reduces renal fibrosis.

Authors:  Michael D Wetzel; Kristen Stanley; Wei Wei Wang; Soumya Maity; Muniswamy Madesh; W Brian Reeves; Alaa S Awad
Journal:  JCI Insight       Date:  2020-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.